The Enterprise Value as of December 2025 (TTM) for Arrowhead Pharmaceuticals, Inc. (ARWR) is 9.52B

According to Arrowhead Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.52B. This represents a change of 258.57% compared to the average of 2.66B of the last 4 quarters.

Arrowhead Pharmaceuticals, Inc. (ARWR) Historical Enterprise Value (quarterly & annually)

How has ARWR Enterprise Value performed in the past?

The mean historical Enterprise Value of Arrowhead Pharmaceuticals, Inc. over the last ten years is 2.92B. The current 9.52B Enterprise Value has changed 32.54% with respect to the historical average. Over the past ten years (40 quarters), ARWR's Enterprise Value was at its highest in in the June 2021 quarter at 8.24B. The Enterprise Value was at its lowest in in the December 2016 quarter at 10.77M.

Arrowhead Pharmaceuticals, Inc. (ARWR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arrowhead Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arrowhead Pharmaceuticals, Inc. (ARWR) Average Enterprise Value

How has ARWR Enterprise Value performed in the past?

The current Enterprise Value of Arrowhead Pharmaceuticals, Inc. (ARWR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arrowhead Pharmaceuticals, Inc. (ARWR) Enterprise Value vs. Peers

How is ARWR’s Enterprise Value compared to its peers?

Arrowhead Pharmaceuticals, Inc.’s Enterprise Value is greater than Vaxcyte, Inc. (5.83B), greater than CRISPR Therapeutics AG (5.11B), greater than PTC Therapeutics, Inc. (5.99B), greater than Arcellx, Inc. (3.78B), greater than Krystal Biotech, Inc. (6.05B), greater than TG Therapeutics, Inc. (5.11B), greater than Alkermes plc (4.29B), greater than Axsome Therapeutics, Inc. (7.35B), greater than Metsera, Inc. (6.98B), greater than Kymera Therapeutics, Inc. (4.74B),

Build a custom stock screener for Arrowhead Pharmaceuticals, Inc. (ARWR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arrowhead Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arrowhead Pharmaceuticals, Inc. (ARWR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arrowhead Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.